Multiomics & Biomarker Discovery

6 Items

This section highlights innovative analytical, technological, and computational approaches for the discovery and validation of circulating biomarkers. It includes multiomics integration (genomics, proteomics, metabolomics, transcriptomics), high‑throughput platforms, liquid biopsy technologies, assay development, biomarker validation frameworks, and AI/ML‑driven analytics. Studies may be methodological, translational, or early diagnostic in scope. Diagnostics and Therapeutics.

Associate Editor: Dr Nelson Soares  | Ongoing call for papers

All Items

  • Dysfunctional high-density lipoprotein predicts survival, renal recovery and the need for kidney replacement therapy in acute kidney injury

    Nikolaos Pagonas, Oliver Pfeifer, Stefan Erfurt, Meike Hoffmeister, Oliver Ritter, Theodoros Kelesidis, Daniel Patschan
    16-27
    DOI: https://doi.org/10.33393/jcb.2026.3584

  • Secretory versus non-secretory hepatocellular carcinoma: associations of serum AFP, CEA and CA19-9 levels with clinical presentation, metastatic patterns, and survival

    Muhammad Emmamally, Urda Kotze, Rufaida Khan, Marc Bernon, Sanju Sobnach, Jake Krige, C. Wendy Spearman, Mark Sonderup, Eduard Jonas
    8-14
    DOI: https://doi.org/10.33393/jcb.2026.3637

  • Association of systemic inflammatory biomarkers with the clinical forms of acute cholecystitis

    Novruz Hajiyev, Jabbar Hajiyev , Najiba Eynullayeva , Vidadi Allahverdiyev , Elman Tagisoy , Ismayil Gafarov
    1-7
    DOI: https://doi.org/10.33393/jcb.2026.3624

  • Anti-CENP-A/B reactivity in samples exhibiting the centromere HEp-2 pattern is associated with a lower frequency of interstitial lung disease in limited cutaneous systemic sclerosis patients

    Gerson D Keppeke, Diana Landoni , Cristiane Kayser , Pedro Matos , Larissa Diogenes , Jessica Keppeke , Silvia Helena Rodrigues , Luis Eduardo C. Andrade
    54-63
    DOI: https://doi.org/10.33393/jcb.2025.3608

  • Association of hypertension and diabetes with COVID-19 severity in comparison to healthy patients

    Muslima Mahmood Ismail, Abdulhakeem Hussein, Othman Ghazi Najeeb, Mohammed Hadi Ali Al-Jumaili
    39-45
    DOI: https://doi.org/10.33393/jcb.2025.3561

  • A comparison of inflammatory markers’ potential to predict weight loss in advanced cancer: a prospective observational study

    Ola Magne Vagnildhaug, Ragnhild H. Habberstad, Øyvind Salvesen, Trude R. Balstad, Asta Bye, Olav Dajani, Stein Kaasa, Pål Klepstad, Tora S. Solheim
    12-20
    DOI: https://doi.org/10.33393/jcb.2025.3510